siRNA targeting tissue factor(siRNAsense/Biomedical Innovation/Biotechnology Centre of Oslo)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamesiRNA targeting tissue factor(siRNAsense/Biomedical Innovation/Biotechnology Centre of Oslo)
Drug Alias NamesiRNA targeting tissue factor (siRNAsense)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionTissue factor modulators
TargetsTissue factor
Therapy Area/IndicationsNeoplasm MetastasisColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Oslo
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniessiRNAsense ASBio-Medisinsk Innovasjon AsUniversity Of Oslo
Active IndicationsN/A
Inactive IndicationsNeoplasm MetastasisColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A